Genistein for the treatment of cystic fibrosis
US5948814A · kind A · utility
29Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 1998 |
| Grant date | Sep 7, 1999 |
| Priority date | — |
| Expiry date | Feb 20, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/352
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cystic fibrosis by generating cystic fibrosis transmembrane conductance regulator (CFTR) function in cells containing mutant CFTR and the therapeutic composition for treatment are described. The method of treatment comprising administering an effective amount of genistein, or genistein analogues and derivatives, to a person afflicted with cystic fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.